About Kuros Biosciences Ltd.

Company Description

With more than 150 years of combined research experience, we feel well-established as leaders in orthobiologics, but we're never content with resting on our laurels. Instead, we continue to forge beyond the accepted solutions for spinal fusion. Our focus is on revolutionizing the field of orthobiologics by developing bone grafts that deliver both targeted and controlled bone healing.

Served area

Worldwide

Headcount

58

Headquarters

Wagistrasse 25, 8952 Schlieren – Switzerland

Shareholder information

Shares outstanding

32,811,378

IPO

Oct. 29, 2002

Stock exchange(s)

SIX Swiss Exchange

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.